162 related articles for article (PubMed ID: 23580698)
1. Diabetes mellitus and prostate cancer risk; a nationwide case-control study within PCBaSe Sweden.
Fall K; Garmo H; Gudbjörnsdottir S; Stattin P; Zethelius B
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1102-9. PubMed ID: 23580698
[TBL] [Abstract][Full Text] [Related]
2. Association of type 2 diabetes mellitus and antidiabetic medication with risk of prostate cancer: a population-based case-control study.
Lin E; Garmo H; Van Hemelrijck M; Adolfsson J; Stattin P; Zethelius B; Crawley D
BMC Cancer; 2020 Jun; 20(1):551. PubMed ID: 32539807
[TBL] [Abstract][Full Text] [Related]
3. Exploring the association between use of gonadotropin releasing hormones agonists and prostate cancer diagnosis per se and diabetes control in men with type 2 diabetes mellitus: a nationwide, population-based cohort study.
Lin E; Garmo H; Van Hemelrijck M; Adolfsson J; Stattin P; Zethelius B; Crawley D
BMC Cancer; 2021 Nov; 21(1):1259. PubMed ID: 34809595
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
Häggström C; Van Hemelrijck M; Zethelius B; Robinson D; Grundmark B; Holmberg L; Gudbjörnsdottir S; Garmo H; Stattin P
Int J Cancer; 2017 Feb; 140(3):611-617. PubMed ID: 27770555
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and HbA1c levels associated with high grade prostate cancer.
Ozbek E; Otunctemur A; Dursun M; Sahin S; Besiroglu H; Koklu I; Erkoc M; Danis E; Bozkurt M
Asian Pac J Cancer Prev; 2014; 15(6):2555-8. PubMed ID: 24761863
[TBL] [Abstract][Full Text] [Related]
6. Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort study.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Armes J; Holmberg L; Adolfsson J; Van Hemelrijck M
BMJ Open; 2018 Mar; 8(3):e020787. PubMed ID: 29549214
[TBL] [Abstract][Full Text] [Related]
7. Diabetes mellitus and risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition.
Tsilidis KK; Allen NE; Appleby PN; Rohrmann S; Nöthlings U; Arriola L; Gunter MJ; Chajes V; Rinaldi S; Romieu I; Murphy N; Riboli E; Tzoulaki I; Kaaks R; Lukanova A; Boeing H; Pischon T; Dahm CC; Overvad K; Quirós JR; Fonseca-Nunes A; Molina-Montes E; Gavrila Chervase D; Ardanaz E; Khaw KT; Wareham NJ; Roswall N; Tjønneland A; Lagiou P; Trichopoulos D; Trichopoulou A; Palli D; Pala V; Tumino R; Vineis P; Bueno-de-Mesquita HB; Malm J; Orho-Melander M; Johansson M; Stattin P; Travis RC; Key TJ
Int J Cancer; 2015 Jan; 136(2):372-81. PubMed ID: 24862312
[TBL] [Abstract][Full Text] [Related]
8. Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.
Beckmann K; Crawley D; Nordström T; Aly M; Olsson H; Lantz A; Binti Abd Jalal N; Garmo H; Adolfsson J; Eklund M; Van Hemelrijck M
JAMA Netw Open; 2019 Nov; 2(11):e1914689. PubMed ID: 31693126
[TBL] [Abstract][Full Text] [Related]
9. Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.
Bill-Axelson A; Garmo H; Lambe M; Bratt O; Adolfsson J; Nyberg U; Steineck G; Stattin P
Eur Urol; 2010 Mar; 57(3):390-5. PubMed ID: 19914773
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity in risk of prostate cancer: A Swedish population-based cohort study of competing risks and Type 2 diabetes mellitus.
Häggström C; Van Hemelrijck M; Garmo H; Robinson D; Stattin P; Rowley M; Coolen ACC; Holmberg L
Int J Cancer; 2018 Oct; 143(8):1868-1875. PubMed ID: 29744858
[TBL] [Abstract][Full Text] [Related]
11. Association between duration and type of androgen deprivation therapy and risk of diabetes in men with prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Häggström C; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
Int J Cancer; 2016 Dec; 139(12):2698-2704. PubMed ID: 27557616
[TBL] [Abstract][Full Text] [Related]
12. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
13. Blood glucose, glucose balance, and disease-specific survival after prostate cancer diagnosis in the Finnish Randomized Study of Screening for Prostate Cancer.
Murtola TJ; Sälli SM; Talala K; Taari K; Tammela TLJ; Auvinen A
Prostate Cancer Prostatic Dis; 2019 Sep; 22(3):453-460. PubMed ID: 30679762
[TBL] [Abstract][Full Text] [Related]
14. Diabetes and the risk of prostate cancer: the role of diabetes treatment and complications.
Velicer CM; Dublin S; White E
Prostate Cancer Prostatic Dis; 2007; 10(1):46-51. PubMed ID: 17033617
[TBL] [Abstract][Full Text] [Related]
15. Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe Sweden.
Akre O; Garmo H; Adolfsson J; Lambe M; Bratt O; Stattin P
Eur Urol; 2011 Sep; 60(3):554-63. PubMed ID: 21664039
[TBL] [Abstract][Full Text] [Related]
16. Fathering of dizygotic twins and risk of prostate cancer: nationwide, population-based case-control study.
Wirén S; Drevin L; Akre O; Robinson D; Stattin P
PLoS One; 2014; 9(10):e110506. PubMed ID: 25337702
[TBL] [Abstract][Full Text] [Related]
17. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
18. Safety of transperineal 14-core systematic prostate biopsy in diabetic men.
Suzuki M; Kawakami S; Asano T; Masuda H; Saito K; Koga F; Fujii Y; Kihara K
Int J Urol; 2009 Dec; 16(12):930-5. PubMed ID: 19796129
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance is inversely related to prostate cancer: a prospective study in Northern Sweden.
Stocks T; Lukanova A; Rinaldi S; Biessy C; Dossus L; Lindahl B; Hallmans G; Kaaks R; Stattin P
Int J Cancer; 2007 Jun; 120(12):2678-86. PubMed ID: 17278097
[TBL] [Abstract][Full Text] [Related]
20. Association between type 2 diabetes, curative treatment and survival in men with intermediate- and high-risk localized prostate cancer.
Crawley D; Garmo H; Rudman S; Stattin P; Zethelius B; Holmberg L; Adolfsson J; Van Hemelrijck M
BJU Int; 2018 Feb; 121(2):209-216. PubMed ID: 28418195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
